#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study of LUMC-BOB1-B7-TCR.

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study of etentamig and iberdomide treatment for patients with relapsed or refractory multiple myeloma

    Recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France The Netherlands Norway

  • Study comparing daratumumab, lenalidomide and dexamethasone followed by linvoseltamab versus continued initial treatment in newly diagnosed multiple myeloma patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Belgium Croatia Czechia Denmark Estonia +10

  • Study of ABBV-453 alone or with drug combination for adults with multiple myeloma: evaluation of safety and effectiveness

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Italy Poland Portugal +1

  • Study on Safe Skin Test Concentrations for Biotherapy Allergies in Patients with Cancer Using Atezolizumab, Daratumumab, and Nivolumab

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study of elranatamab and lenalidomide combination versus standard chemotherapy and transplant in newly diagnosed multiple myeloma patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium France

  • Study on the Safety and Effects of Inobrodib, Betamethasone Sodium Phosphate, and Dimethyl Fumarate in Patients with Advanced Blood and Bone Marrow Cancers

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study Comparing Belantamab Mafodotin with Lenalidomide and Dexamethasone to Daratumumab with Lenalidomide and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Belgium Czechia France Germany Greece +5

  • Study Comparing Elranatamab and Lenalidomide with Daratumumab and Lenalidomide for Maintenance Therapy in Newly Diagnosed Multiple Myeloma Patients

    Recruiting

    2 1 1 1
    Investigated Drugs:
    France

  • Study of IDP-121 for Patients with Relapsed or Refractory Multiple Myeloma, B-cell Lymphoma, or Chronic Lymphocytic Leukemia

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain